Literature DB >> 26540464

Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.

Tihami Qureshi1, Cynthia B Peterson1.   

Abstract

The serine protease inhibitor (serpin), plasminogen activator inhibitor-1 (PAI-1), is an important biomarker for cardiovascular disease and many cancers. It is therefore a desirable target for pharmaceutical intervention. However, to date, no PAI-1 inhibitor has successfully reached clinical trial, indicating the necessity to learn more about the mechanics of the serpin. Although its kinetics of inhibition have been extensively studied, less is known about the latency transition of PAI-1, in which the solvent-exposed reactive center loop (RCL) inserts into its central β-sheet, rendering the inhibitor inactive. This spontaneous transition is concomitant with a large translocation of the RCL, but no change in covalent structure. Here, we conjugated the fluorescent probe, NBD, to single positions along the RCL (P13-P5') to detect changes in solvent exposure that occur during the latency transition. The results support a mousetrap-like RCL-insertion that occurs with a half-life of 1-2 h in accordance with previous reports. Importantly, this study exposes unique transitions during latency that occur with a half-life of ∼5 and 25 min at the P5' and P8 RCL positions, respectively. We hypothesize that the process detected at P5' represents s1C detachment, while that at P8 results from a steric barrier to RCL insertion. Together, these findings provide new insights by characterizing multiple steps in the latency transition.
© 2015 The Protein Society.

Entities:  

Keywords:  PAI-1; RCL; latency transition; serpin

Mesh:

Substances:

Year:  2015        PMID: 26540464      PMCID: PMC4815349          DOI: 10.1002/pro.2839

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  53 in total

1.  Immobilization of the distal hinge in the labile serpin plasminogen activator inhibitor 1: identification of a transition state with distinct conformational and functional properties.

Authors:  Bart De Taeye; Griet Compernolle; Maarten Dewilde; Wouter Biesemans; Paul J Declerck
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

2.  Serpin mutagenesis.

Authors:  Toni M Antalis; Daniel A Lawrence
Journal:  Methods       Date:  2004-02       Impact factor: 3.608

3.  Local transient unfolding of native state PAI-1 associated with serpin metastability.

Authors:  Morten B Trelle; Jeppe B Madsen; Peter A Andreasen; Thomas J D Jørgensen
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-22       Impact factor: 15.336

Review 4.  The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment.

Authors:  Troels Wind; Martin Hansen; Jan K Jensen; Peter A Andreasen
Journal:  Biol Chem       Date:  2002-01       Impact factor: 3.915

5.  The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.

Authors:  Peter Hägglöf; Fredrik Bergström; Malgorzata Wilczynska; Lennart B-A Johansson; Tor Ny
Journal:  J Mol Biol       Date:  2004-01-16       Impact factor: 5.469

6.  Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies.

Authors:  Andrey A Komissarov; Paul J Declerck; Joseph D Shore
Journal:  J Biol Chem       Date:  2002-09-09       Impact factor: 5.157

7.  Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1.

Authors:  Grant E Blouse; Michel J Perron; Jan-Olov Kvassman; Saadia Yunus; Jannah H Thompson; Russell L Betts; Leonard C Lutter; Joseph D Shore
Journal:  Biochemistry       Date:  2003-10-28       Impact factor: 3.162

8.  A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.

Authors:  Grant E Blouse; Michel J Perron; Jannah H Thompson; Duane E Day; Chad A Link; Joseph D Shore
Journal:  Biochemistry       Date:  2002-10-08       Impact factor: 3.162

9.  Reaction of thrombins with human antithrombin III. I. Enzyme activity losses unrelated to the inhibitory reaction and their prevention.

Authors:  Z S Latallo; J A Hall
Journal:  Thromb Res       Date:  1986-09-01       Impact factor: 3.944

10.  Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry.

Authors:  Morten B Trelle; Daniel M Dupont; Jeppe B Madsen; Peter A Andreasen; Thomas J D Jørgensen
Journal:  ACS Chem Biol       Date:  2013-11-14       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.